AR085272A1 - Cepa del prrsv (virus del sindrome reproductor y respiratorio porcino) europea - Google Patents

Cepa del prrsv (virus del sindrome reproductor y respiratorio porcino) europea

Info

Publication number
AR085272A1
AR085272A1 ARP120100538A ARP120100538A AR085272A1 AR 085272 A1 AR085272 A1 AR 085272A1 AR P120100538 A ARP120100538 A AR P120100538A AR P120100538 A ARP120100538 A AR P120100538A AR 085272 A1 AR085272 A1 AR 085272A1
Authority
AR
Argentina
Prior art keywords
seq
prrs
virus
prrsv
respiratory syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ARP120100538A
Other languages
English (en)
Inventor
Kim Burgard
Jeremy Kroll
Sarah M Layton
Volker Ohlinger
Francois Orveillon
Stefan Xavier-Pesch
Michael Dennis Piontkowski
Michael B Roof
Philip Utley
Eric Martin Vaughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Original Assignee
Boehringer Ingelheim Vetmedica GmbH
Boehringer Ingelheim Vetmedica de C V SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica GmbH, Boehringer Ingelheim Vetmedica de C V SA filed Critical Boehringer Ingelheim Vetmedica GmbH
Publication of AR085272A1 publication Critical patent/AR085272A1/es
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10071—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un virus del síndrome reproductor y respiratorio porcino (PRRSV) de un tipo europeo, caracterizado porque es de la cepa depositada en la Colección europea de cultivos celulares (ECACC) con el número de acceso ECACC 11012501 o el número de acceso ECACC 11012502.Reivindicación 4: Una vacuna para la protección de cerdos contra la infección por PRRSV, caracterizada porque comprende el PRRSV atenuado vivo según la reivindicación 1 y un vehículo farmacéuticamente aceptable. Reivindicación 11: Un procedimiento para la preparación de una vacuna atenuada viva para combatir PRRS, caracterizado porque comprende mezclar un PRRSV atenuado vivo según la reivindicación 1 con un vehículo farmacéuticamente aceptable. Reivindicación 14: Un procedimiento de inmunizar cerdos contra el síndrome reproductor y respiratorio porcino (PRRS), caracterizado porque comprenden la etapa de administrar al cerdo una composición de vacuna que incluye un virus vivo del síndrome reproductor y respiratorio porcino mezclado con un agente de vehículo farmacológicamente compatible, comprendiendo dicho virus el virus 94881 deI PRRS pasado al menos 36 veces por cultivo celular para modificar el virus de forma que cuando el virus modificado se administre a un cerdo u otro mamífero propenso al PRRS fracase en producir signos clínicos de enfermedad de PRRS, pero pueda inducir una respuesta inmunitaria que inmunice al mamífero contra formas patógenas del PRRS. Reivindicación 23: Un ácido nucleico aislado, caracterizado porque comprende una secuencia seleccionada del grupo que consiste en SEC ID Nº 19; SEC ID Nº 20; SEC ID Nº 21; SEC ID Nº 22; SEC ID Nº 23; SEC ID Nº 24; SEC ID Nº 25; SEC ID Nº 26; SEC ID Nº 27; SEC ID Nº 28; SEC ID Nº 29; SEC ID Nº 30; SEC ID Nº 31; SEC ID Nº 32; SEC ID Nº 33 y SEC ID Nº 34.
ARP120100538A 2011-02-17 2012-02-16 Cepa del prrsv (virus del sindrome reproductor y respiratorio porcino) europea Pending AR085272A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161444074P 2011-02-17 2011-02-17

Publications (1)

Publication Number Publication Date
AR085272A1 true AR085272A1 (es) 2013-09-18

Family

ID=45614840

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP120100538A Pending AR085272A1 (es) 2011-02-17 2012-02-16 Cepa del prrsv (virus del sindrome reproductor y respiratorio porcino) europea
ARP190103882A AR117530A2 (es) 2011-02-17 2019-12-30 Una composición que comprende un virus del síndrome reproductor y respiratorio porcino (prrsv) de un tipo europeo, un producto de vacuna, una composición de proteína, un ácido nucleico aislado y un vector de expresión recombinante

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP190103882A AR117530A2 (es) 2011-02-17 2019-12-30 Una composición que comprende un virus del síndrome reproductor y respiratorio porcino (prrsv) de un tipo europeo, un producto de vacuna, una composición de proteína, un ácido nucleico aislado y un vector de expresión recombinante

Country Status (30)

Country Link
US (4) US8765142B2 (es)
EP (2) EP2675475B1 (es)
JP (1) JP5788027B2 (es)
KR (2) KR102183276B1 (es)
CN (2) CN103370078B (es)
AR (2) AR085272A1 (es)
AU (2) AU2012217169B2 (es)
BR (2) BR112013021076B1 (es)
CA (1) CA2826341C (es)
CL (1) CL2013002379A1 (es)
CO (1) CO6791570A2 (es)
CY (1) CY1116835T1 (es)
DK (2) DK2959916T3 (es)
EA (2) EA038012B1 (es)
ES (2) ES2550258T3 (es)
HR (1) HRP20151031T1 (es)
HU (1) HUE027731T2 (es)
ME (1) ME02271B (es)
MX (2) MX355058B (es)
MY (2) MY161198A (es)
PH (1) PH12017500962A1 (es)
PL (2) PL2959916T3 (es)
PT (2) PT2675475E (es)
RS (1) RS54231B1 (es)
SG (1) SG192820A1 (es)
SI (1) SI2675475T1 (es)
SM (1) SMT201500236B (es)
TW (2) TWI665303B (es)
UA (2) UA112768C2 (es)
WO (1) WO2012110489A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA031432B1 (ru) 2011-02-17 2019-01-31 Бёрингер Ингельхайм Ветмедика Гмбх Способ получения вируса репродуктивно-респираторного сидрома свиней prrs
EA038012B1 (ru) 2011-02-17 2021-06-23 Бёрингер Ингельхайм Ветмедика Гмбх Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
US8906385B2 (en) 2011-12-01 2014-12-09 University Of Maryland, College Park Interferon-inducing porcine reproductive and respiratory syndrome virus isolate
JP6386999B2 (ja) 2012-05-17 2018-09-05 ゾエティス・エルエルシー ブタ生殖および呼吸症候群（ｐｒｒｓ）ウイルスに対する離乳前の効果的なワクチン接種
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
US9457073B2 (en) * 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
US9149518B2 (en) 2012-12-07 2015-10-06 The Board Of Trustees Of The University Of Illinois Porcine reproductive and respiratory syndrome virus compositions and uses thereof
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
EA039060B1 (ru) * 2013-12-20 2021-11-29 Бёрингер Ингельхайм Ветмедика Гмбх Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) * 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
PT3212182T (pt) 2014-10-27 2019-07-29 Pharmacosmos Holding As Tratamento ou prevenção da anemia em mamíferos não humanos em período de gestação e ninhada
CN106924726B (zh) * 2015-12-29 2021-02-09 普莱柯生物工程股份有限公司 一种用于预防猪繁殖与呼吸综合征的疫苗组合物及其制备方法和应用
EP3454893A4 (en) * 2016-05-11 2020-01-01 Phibro Animal Health Corporation COMPOSITION WITH ANTIGENS AND A MUCUTINE ADJUVAN AND METHOD FOR USE
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
PT3534939T (pt) 2016-11-03 2023-04-20 Boehringer Ingelheim Vetmedica Gmbh Vacina contra parvovírus porcino e vírus da síndrome reprodutiva e respiratória porcina e métodos da sua produção
CN110072547B (zh) * 2016-12-14 2024-04-30 硕腾服务有限责任公司 断奶前对抗欧洲猪繁殖与呼吸综合征(prrs)病毒株的有效疫苗接种
US11013796B2 (en) 2018-08-30 2021-05-25 Iowa State University Research Foundation, Inc. Porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom
EP3953370A1 (en) 2019-04-04 2022-02-16 Boehringer Ingelheim Animal Health USA Inc. Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof
CN110735005B (zh) * 2019-11-26 2023-01-10 广西大学 Siv和prrsv多重rt-pcr快速检测试剂盒及引物
CN111676247A (zh) * 2020-06-30 2020-09-18 扬州大学 一株猪繁殖与呼吸综合征病毒1型分离株感染性克隆构建、拯救与应用
EP4185321A2 (en) 2020-07-24 2023-05-31 Boehringer Ingelheim Animal Health USA Inc. Combination porcine vaccine
CN113862230B (zh) * 2021-09-30 2023-08-08 中牧实业股份有限公司 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE148705C (es)
US3137631A (en) 1959-12-01 1964-06-16 Faberge Inc Encapsulation in natural products
US3080291A (en) 1960-06-10 1963-03-05 Jensen Salsberg Lab Inc Serial passage of distemper virus in tissue cultures of chick embryo and canine tissue and vaccine therefrom
US3959457A (en) 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
US4015100A (en) 1974-01-07 1977-03-29 Avco Everett Research Laboratory, Inc. Surface modification
US4122167A (en) 1977-02-09 1978-10-24 Merck & Co., Inc. Respiratory synctial vaccine
US4205060A (en) 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
US4224412A (en) 1979-05-01 1980-09-23 Dorofeev Viktor M Living virus culture vaccine against canine distemper and method of preparing same
US4554159A (en) 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US4452747A (en) 1982-03-22 1984-06-05 Klaus Gersonde Method of and arrangement for producing lipid vesicles
GB8319302D0 (en) 1983-07-16 1983-08-17 Tpt Ltd Container
US4468346A (en) 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
DE3405100A1 (de) 1984-02-14 1985-08-14 Drägerwerk AG, 2400 Lübeck Pt-katalysator auf einem traeger als luftreinigungsmittel
US4744933A (en) 1984-02-15 1988-05-17 Massachusetts Institute Of Technology Process for encapsulation and encapsulated active material system
US5008050A (en) 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4921706A (en) 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
EP0208672B1 (en) 1985-07-08 1993-02-17 REGION WALLONNE représentée par le Ministre des Technologies pour la Région wallonne dans ses attributions Vaccines and diagnostics derived from bovine diarrhea virus
US5206163A (en) 1985-07-08 1993-04-27 Chiron Corporation DNA encoding bovine diarrhea virus protein
US4753884A (en) 1986-01-28 1988-06-28 Novagene, Inc. Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
JPS62198626A (ja) 1986-02-26 1987-09-02 Biseibutsu Kagaku Kenkyusho:Kk 血球凝集性脳脊髄炎ウイルス感染症予防ワクチン
FR2602791B1 (fr) 1986-08-18 1988-11-10 Ministere Agri Direction Quali Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu
NZ222465A (en) 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
US5009956A (en) 1987-02-24 1991-04-23 Univ Minnesota Phospholipase A2-resistant liposomes
DE3833925A1 (de) 1988-03-11 1989-09-21 Inst Angewandte Biotechnologie Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu
US5213759A (en) 1988-05-05 1993-05-25 Elopak Systems A.G. Sterilization
US4927637A (en) 1989-01-17 1990-05-22 Liposome Technology, Inc. Liposome extrusion method
US4944948A (en) 1989-02-24 1990-07-31 Liposome Technology, Inc. EGF/Liposome gel composition and method
US5132117A (en) 1990-01-11 1992-07-21 Temple University Aqueous core microcapsules and method for their preparation
AU7007491A (en) 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
HU218431B (hu) 1991-06-06 2000-08-28 Stichting Centraal Diergeneeskundig Instituut A rejtélyes sertésvészt okozó Lelystad-vírus, a vírusból származtatható polipeptidek, antigének és nukleinsavak és rejtélyes sertésvész elleni vakcinakészítmények
US6042830A (en) 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
MX9204885A (es) 1991-08-26 1994-05-31 Boehringer Animal Health Inc Composicion de vacuna que comprende virus del sindrome de infertilidad y respiratorio de los cerdos.
US6080570A (en) 1991-08-26 2000-06-27 Boehringer Ingelheim Vetmedica, Inc. Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
US6982160B2 (en) 1991-08-26 2006-01-03 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions that include SIRS virus
DK0601062T4 (da) 1991-08-26 2001-03-14 Univ Minnesota SIRS-vaccine og diagnosefremgangsmåde
US5846805A (en) 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
AU2696792A (en) 1991-09-16 1993-04-27 David A Benfield Vaccine for mystery swine disease and method for diagnosis thereof
ES2083764T5 (es) 1991-10-14 2009-04-01 Intervet International Bv Vacuna para el sindrome respiratorio reproductivo porcino (srrp) y diagnostico.
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
TW289731B (es) 1992-07-09 1996-11-01 Akzo Nv
US6773908B1 (en) 1992-10-30 2004-08-10 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6251397B1 (en) 1992-10-30 2001-06-26 Iowa State University Research Foundation, Inc. Proteins encoded by polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus and immunogenic compositions containing the same
US5695766A (en) 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
US6380376B1 (en) 1992-10-30 2002-04-30 Iowa State University Research Foundation Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)
US6592873B1 (en) 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
US5419907A (en) 1992-11-10 1995-05-30 Iowa State University Research Foundation, Inc. Pathogenic porcine respiratory coronavirus
KR100374295B1 (ko) 1993-02-08 2003-12-24 바이엘 코포레이션 돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도
ES2074950B1 (es) 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
EP0659885A1 (en) 1993-12-21 1995-06-28 Akzo Nobel N.V. Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity
DE4407489A1 (de) 1994-03-07 1995-09-14 Bayer Ag Vakzine zur Prävention von Respirations- und Reproduktionserkrankungen des Schweines
EP0676467B1 (en) 1994-04-11 2001-10-04 Akzo Nobel N.V. European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
CA2187768A1 (en) 1994-04-15 1995-10-26 Moser, Charlotte A. Aqueous solvent encapsulation method, apparatus and microcapsules
GB2289279B (en) 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
CA2196555C (en) 1994-08-05 2012-07-03 Michael P. Murtaugh Vr-2332 viral nucleotide sequence and methods of use
DK0732340T3 (da) 1995-03-14 2004-10-25 Akzo Nobel Nv Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle
US5690940A (en) 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof
ES2102971B1 (es) 1996-01-25 1998-03-01 Hipra Lab Sa Nueva cepa atenuada del virus causante del sindrome respiratorio y reproductivo porcino (prrs), las vacunas y medios de diagnostico obtenibles con la misma y los procedimientos para su obtencion.
ZA971663B (en) 1996-03-01 1997-08-26 Schering Corp Porcine reproductive and respiratory syndrome vaccine.
US5866401A (en) 1996-03-01 1999-02-02 Schering Corporation Porcine reproductive and respiratory syndrome vaccine
US6015663A (en) 1996-03-01 2000-01-18 The United States Of America As Represented By The Secretary Of Agriculture Restriction enzyme screen for differentiating porcine reproductive and respiratory syndrome virus strains
US5976537A (en) 1996-07-02 1999-11-02 The United States Of America As Represented By The Secretary Of Agriculture Porcine reproductive and respiratory syndrome vaccine
ES2157522T3 (es) 1996-10-09 2001-08-16 Akzo Nobel Nv Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv).
EP0839912A1 (en) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
US20040224327A1 (en) 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO1998035023A1 (en) * 1997-02-07 1998-08-13 Origen, Inc. Method for growing porcine reproductive and respiratory syndrome virus for use as vaccines and diagnostic assays
UA73915C2 (uk) 1997-05-06 2005-10-17 Стіхтінг Дінст Ландбаувкюндіг Ондерзук Пептид, який індукує утворення нейтралізуючих антитіл (варіанти), антитіло, одержане за допомогою вказаного пептиду, імуногенна композиція для індукції нейтралізуючих антитіл, вакцина для профілактики зараження репродуктивно-респіраторним синдромом свиней (ррсс) та діагностичний набір для виявлення або ідентифікації антитіл, специфічних до ізоляту вррсс
JP2002510205A (ja) 1997-06-04 2002-04-02 カルジーン エルエルシー ポリケチド様合成遺伝子を植物内で発現させることによる多不飽和脂肪酸の製造
WO1998055626A2 (en) 1997-06-05 1998-12-10 Origen, Inc. Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
US7211379B2 (en) 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US7132106B2 (en) 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US7618797B2 (en) 1998-12-22 2009-11-17 Pfizer Inc Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
NZ513289A (en) 1998-12-22 2003-04-29 Pfizer Prod Inc Infectious cDNA clone of north american procine reproductive and respiratory syndrome (PRRS) virus and uses thereof
US7691389B2 (en) 1998-12-22 2010-04-06 Pfizer Inc Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
WO2000065032A1 (en) 1999-04-22 2000-11-02 United States Department Of Agriculture Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
US20040213805A1 (en) 1999-10-12 2004-10-28 Verheije Monique Helene Deletions in arterivirus replicons
WO2002095040A1 (en) 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
US20020012670A1 (en) 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
EP1255815B1 (en) * 2000-02-08 2006-07-19 Regents Of The University Of Minnesota Porcine reproductive and respiratory syndrome virus and methods of use
EP1156111A1 (en) 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
US7018638B2 (en) 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MXPA03007751A (es) * 2001-03-09 2004-11-12 Boehringer Ingelheim Vetmed Cepas vivas atenuadas del virus prrs.
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US6841364B2 (en) 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
ATE557082T1 (de) 2002-04-05 2012-05-15 Boehringer Ingelheim Vetmed Sequenz positionen zur anpassung bei prrsv
US7335361B2 (en) 2003-06-09 2008-02-26 Animal Technology Institute Taiwan Fusion antigen used as vaccine
US7722878B2 (en) 2004-06-17 2010-05-25 Boehringer Ingelheim Vetmedica, Inc. PRRSV subunit vaccines
CN101039693A (zh) * 2004-06-18 2007-09-19 明尼苏达大学董事会 鉴定病毒感染和疫苗接种的生物
US7611717B2 (en) 2004-06-18 2009-11-03 Regents Of The University Of Minnesota Identifying virally infected and vaccinated organisms
US20060063151A1 (en) 2004-09-21 2006-03-23 Michael Roof Porcine reproductive and respiratory syndrome isolates and methods of use
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
US7879337B2 (en) * 2004-11-11 2011-02-01 Pfizer Inc. Mutant porcine reproductive and respiratory syndrome virus
KR101152012B1 (ko) * 2004-11-19 2012-07-04 인터벳 인터내셔널 비.브이. 돼지 생식기 및 호흡기 증후군 바이러스 균주 및 조성물
DE602006013270D1 (en) 2005-01-13 2010-05-12 Boehringer Ingelheim Vetmed Prrs-impfstoffe
UA95778C2 (ru) 2005-06-24 2011-09-12 Риджентс Оф Зе Юниверсити Оф Миннесота Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
US7622254B2 (en) * 2005-11-29 2009-11-24 Iowa State University Research Foundation, Inc. Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
US8563313B2 (en) 2007-02-13 2013-10-22 Washington State University Research Foundation Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus
WO2008121958A1 (en) 2007-04-02 2008-10-09 Boehringer Ingelheim Vetmedica, Inc. Use of prrsv vaccines to reduce pcv2 viremia
US20100003278A1 (en) 2008-07-03 2010-01-07 Boehringer Ingelheim Vetmedica, Inc. Immunological Compositions Effective for Lessening the Severity or Incidence of PRRSV Signs and Methods of Use Thereof
RU2561595C2 (ru) 2008-08-25 2015-08-27 Бёрингер Ингельхайм Ветмедика, Инк. Вакцина против высокопатогенного репродуктивно-респираторного синдрома свиней (hp prrs)
US20100129398A1 (en) 2008-11-26 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome
EP2558118B1 (en) 2010-04-16 2019-06-05 Universiteit Gent Cross-protecting vaccine for porcine reproductive and respiratory syndrome virus
CN101920010A (zh) * 2010-06-29 2010-12-22 西北农林科技大学 表达prrsv免疫原基因的重组减毒鼠伤寒沙门氏菌载体疫苗及其制备方法
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
EA031432B1 (ru) * 2011-02-17 2019-01-31 Бёрингер Ингельхайм Ветмедика Гмбх Способ получения вируса репродуктивно-респираторного сидрома свиней prrs
EA038012B1 (ru) 2011-02-17 2021-06-23 Бёрингер Ингельхайм Ветмедика Гмбх Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
EP2737059A1 (en) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Novel prrs virus inducing type i interferon in susceptible cells
CN105073130A (zh) 2013-03-15 2015-11-18 勃林格殷格翰动物保健公司 猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法
EA039060B1 (ru) 2013-12-20 2021-11-29 Бёрингер Ингельхайм Ветмедика Гмбх Вариант вируса ppcc, способ его получения с помощью молекулы нуклеиновой кислоты, конструкции днк или клетки и его применение для лечения и профилактики ррсс

Also Published As

Publication number Publication date
PL2675475T3 (pl) 2015-12-31
US20120213810A1 (en) 2012-08-23
CY1116835T1 (el) 2017-03-15
US20170065709A1 (en) 2017-03-09
PH12017500962A1 (en) 2017-11-20
EA201692359A1 (ru) 2017-04-28
MX345188B (es) 2017-01-20
SG192820A1 (en) 2013-09-30
KR102183276B1 (ko) 2020-11-26
US20140255442A1 (en) 2014-09-11
CA2826341C (en) 2022-02-22
SMT201500236B (it) 2015-10-30
TW201638333A (zh) 2016-11-01
RS54231B1 (en) 2015-12-31
MX355058B (es) 2018-04-04
PT2959916T (pt) 2018-11-19
AU2016204983A1 (en) 2016-08-04
BR122021013826B1 (pt) 2022-11-22
EA038012B1 (ru) 2021-06-23
MY161198A (en) 2017-04-14
EP2959916A1 (en) 2015-12-30
TW201300538A (zh) 2013-01-01
CN106110318A (zh) 2016-11-16
PT2675475E (pt) 2015-10-22
AU2016204983B2 (en) 2018-02-15
HRP20151031T1 (hr) 2015-11-06
EP2675475A2 (en) 2013-12-25
MX2013009485A (es) 2014-07-09
US8765142B2 (en) 2014-07-01
SI2675475T1 (sl) 2015-10-30
WO2012110489A3 (en) 2012-10-11
BR112013021076A2 (pt) 2020-12-15
EP2675475B1 (en) 2015-07-01
KR20140006040A (ko) 2014-01-15
CL2013002379A1 (es) 2014-02-14
UA112768C2 (uk) 2016-10-25
US10668144B2 (en) 2020-06-02
DK2959916T3 (en) 2018-10-29
US10039821B2 (en) 2018-08-07
US20190134180A1 (en) 2019-05-09
MY186535A (en) 2021-07-26
AU2012217169B2 (en) 2016-08-11
EA201300915A1 (ru) 2014-02-28
WO2012110489A2 (en) 2012-08-23
TWI665303B (zh) 2019-07-11
JP2014507151A (ja) 2014-03-27
CA2826341A1 (en) 2012-08-23
CO6791570A2 (es) 2013-11-14
KR102073075B1 (ko) 2020-02-26
CN103370078A (zh) 2013-10-23
ES2692809T3 (es) 2018-12-05
CN103370078B (zh) 2016-08-10
JP5788027B2 (ja) 2015-09-30
AR117530A2 (es) 2021-08-11
TWI673362B (zh) 2019-10-01
EA035624B1 (ru) 2020-07-16
ME02271B (me) 2016-02-20
EP2959916B1 (en) 2018-08-08
UA117272C2 (uk) 2018-07-10
HUE027731T2 (en) 2016-10-28
US9534207B2 (en) 2017-01-03
KR20200015800A (ko) 2020-02-12
PL2959916T3 (pl) 2019-05-31
DK2675475T3 (en) 2015-09-14
ES2550258T3 (es) 2015-11-05
BR112013021076B1 (pt) 2022-11-29
AU2012217169A1 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
AR085272A1 (es) Cepa del prrsv (virus del sindrome reproductor y respiratorio porcino) europea
ES2349041T3 (es) Derivados de hidantoina para el tratamiento de trastornos inflamatorios.
AR107020A2 (es) Vacuna de pcsk9 (proteína convertasa subtilisina-kexina tipo 9)
ES2762535T3 (es) Virus de la pseudorrabia de los porcinos, composición de vacuna y método de preparación y uso de la misma
NZ586238A (en) Methods and compositions for immunizing pigs against porcine circovirus
TWI579297B (zh) 用於預防豬病感染之混合疫苗
JP2019151636A5 (es)
BRPI0917887A2 (pt) vacina contra síndrome reprodutiva e respiratória suína altamente patogênica (hp pprs)
US11389525B2 (en) Polygene influenza vaccine
NZ616304A (en) Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
AR053327A1 (es) Vacunas mejoradas del vsrrp, metodo para preparar y su uso
Zhang et al. Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effect of a DNA vaccine against spring viremia of carp virus in common carp
ITTO940713A1 (it) Vaccino per la prevenzione della sindrome riproduttiva e respiratoria porcina.
NZ602693A (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
AR093185A1 (es) Virus prrs (sindrome reproductivo y respiratorio porcino) que induce al interferon tipo i en celulas susceptibles
FI3534939T3 (fi) Rokote sian parvovirusta ja sian hedelmättömyyttä ja respiratorista oireyhtymää aiheuttamaa virusta vastaan ja menetelmän sen valmistamiseksi
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
Lee et al. Newly emerging human coronaviruses: animal models and vaccine research for SARS, MERS, and COVID-19
AU2021290231A1 (en) Arthrogenic alphavirus vaccine
CO2021005066A2 (es) Vacuna de ibv 4/91 con proteína espicular heteróloga
Nauwynck et al. Micro‐Dissecting the Pathogenesis and Immune Response of PRRSV Infection Paves the Way for More Efficient PRRSV Vaccines
EP2454374B1 (en) Oral vaccines produced and administered using edible micro-organism
Cheng et al. Protective immune responses in rabbits induced by a suicidal DNA vaccine of the VP60 gene of rabbit hemorrhagic disease virus
Dong et al. Immune responses of mice immunized by DNA plasmids encoding PCV2 ORF 2 gene, porcine IL-15 or the both
WO2011160563A1 (zh) 新型的猪干扰素及其应用

Legal Events

Date Code Title Description
FG Grant, registration